NEW YORK, Sept. 21, 2016 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company")(NASDAQ: SPPI) arising from possible breaches of fiduciary duty by certain of its officers and directors in connection with the Company's pursuit of Food and Drug Administration approval of its proposed bladder cancer drug apaziquone.

Click here for more information about our investigation of SPPI: http://hkh-lawfirm.com/investigations-cases/spectrum-pharmaceuticals-inc-sppi/

Hynes Keller & Hernandez, LLC is a national law firm that represents institutional and individual investors. The firm is focused on providing exemplary legal services in the area of shareholder litigation. The firm has an experienced litigation team which has achieved significant victories on behalf of the firm's clients. You can visit our website at www.hkh-lawfirm.com for more information. Attorney advertising. Prior results do not guarantee similar outcomes.

If you hold shares in SPPI and would like to obtain additional information about your legal rights and protect your investment, please visit our website or contact the attorneys below. There is no cost or obligation to you. 



    Contact:


    Hynes Keller & Hernandez, LLC Hynes Keller & Hernandez, LLC

    Michael J. Hynes, Esq.        Beth A. Keller, Esq.

    1150 First Avenue, Suite 501  118 North Bedford Road, Suite
                                   100

    King of Prussia, PA 19406     Mount Kisco, NY 10549

    Telephone: (610) 994-0292     Telephone: (914) 752-3040

    Email: mhynes@hkh-lawfirm.com Email: bkeller@hkh-lawfirm.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hynes-keller--hernandez-llc-announces-investigation-of-spectrum-pharmaceuticals-inc-sppi-300331550.html

SOURCE Hynes Keller & Hernandez, LLC